| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | AVITA MEDICAL INC.: Statement of CDIs on issue - AVH | 14 | ASX | ||
| Di | AVITA MEDICAL INC.: Change of Director's Interest Notice - MT | 2 | ASX | ||
| AVITA MEDICAL Aktie jetzt für 0€ handeln | |||||
| Di | AVITA MEDICAL INC.: Notification regarding unquoted securities - AVH | 1 | ASX | ||
| Di | AVITA MEDICAL INC.: Notification of cessation of securities - AVH | 1 | ASX | ||
| 16.09. | AVITA Medical hebt Prognose an und signalisiert Turnaround nach schwierigem Jahr | 21 | Investing.com Deutsch | ||
| 15.09. | AVITA MEDICAL INC.: Notification of cessation of securities - AVH | 16 | ASX | ||
| 11.09. | AVITA MEDICAL INC.: Statement of CDIs on issue - AVH | 1 | ASX | ||
| 10.09. | AVITA MEDICAL INC.: Notification regarding unquoted securities - AVH | 1 | ASX | ||
| 10.09. | AVITA MEDICAL INC.: Notification regarding unquoted securities - AVH | 1 | ASX | ||
| 09.09. | AVITA MEDICAL INC.: Notification regarding unquoted securities - AVH | 1 | ASX | ||
| 07.09. | AVITA MEDICAL INC.: Notification of cessation of securities - AVH | 1 | ASX | ||
| 25.08. | AVITA Medical, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 19.08. | TD Cowen erhöht Kursziel für Avita Medical nach PermeaDerm-Daten | 4 | Investing.com Deutsch | ||
| 19.08. | BTIG raises Avita Medical stock price target on positive trial data | 6 | Investing.com | ||
| 19.08. | Wednesday's HotCopper trends: Horseshoe Metals, Avita Medical, DXN and other daily topics | 1 | The Market Online Australia | ||
| 19.08. | AVITA MEDICAL INC.: AVITA Investor Webinar Slides on PermeaDerm | 2 | ASX | ||
| 19.08. | AVITA MEDICAL INC.: AVITA announces positive PermeaDerm study results | 2 | ASX | ||
| 18.08. | AVITA Medical's PermeaDerm shows 70% cost savings over allograft | 1 | Investing.com | ||
| 18.08. | AVITA Medical: Studie belegt 70 % Kostenersparnis bei Wundmatrix PermeaDerm | - | Investing.com Deutsch | ||
| 12.08. | AVITA Medical auf Wachstumskonferenz von Canaccord: Wachstum kehrt zurück | 3 | Investing.com Deutsch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 12,350 | +1,56 % | BRANDMELDUNG bei Eckert&Ziegler: Diese brandneue Prognose ändert einfach alles - Mein Rat: sofort handeln! | ||
| UNITEDHEALTH | 329,00 | -0,54 % | UnitedHealth (NYSE:UNH): America's Health System Creates The Opportunity For The Largest Listed Health Care Company! | ||
| MCKESSON | 835,20 | +0,63 % | ROUNDUP/Aktien New York: Gewinne - S&P 500 und Nasdaq 100 mit Rekorden | NEW YORK (dpa-AFX) - Mit Gewinnen und Höchstständen der Leitindizes S&P 500 und Nasdaq 100 sind die US-Aktienmärkte am Dienstag in den Handel gestartet. Begründet wird die freundliche Tendenz mit einer... ► Artikel lesen | |
| SENSEONICS | 8,150 | +1,24 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| ELEKTA | 4,780 | +0,84 % | Elekta AB: New phase 2 data show favorable cognitive outcomes with Leksell Gamma Knife in patients with up to 50 brain metastases | BOSTON - Elekta (EKTA-B.ST) today announced new phase 2 data, presented at ASTRO by lead investigator Dr. Chia-Lin Tseng, demonstrating favorable cognitive outcomes with Leksell Gamma Knife® radiosurgery... ► Artikel lesen | |
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | Alignment Healthcare earns 4-Star or higher ratings for six plans | ||
| HEARTFLOW | 47,590 | -0,08 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PROGYNY | 27,820 | -0,04 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| AVEANNA HEALTHCARE | 12,235 | -0,04 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PRIVIA HEALTH GROUP | 20,180 | -0,05 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| GENEDX | 67,67 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| FRESENIUS | 42,480 | +2,14 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen |